Based on comments from the ASM attendees regarding the "ramp up" prior to FDA green light on current customer BLA application(s)...Halo pr from the other day... Halozyme Announces FDA Has Accepted Biologics License Application For Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Enhanze® Technology -U.S. Food Drug and Administration Expected to Decide on Approval by October 18, 2020 - https://finance.yahoo.com/news/halozyme-announces-fda-accepted-biologics-062000542.html ...don't know if the analysts will ask on this cc or will wait until july to get some idea of revs based on positive approval assumption and the "ramp up" possibility?...imao...r